July 03, 2018
Loan Agreement and Notice of Results
The Company announces that it has entered into an unsecured £1,000,000 loan facility agreement (“Loan Facility”) with Vulpes Lifesciences Fund (“Vulpes”) to be used for working capital purposes.
As announced at the time of the AGM on 30 May 2018, the Company has been in discussions with a number of larger shareholders who remain supportive and will provide non-dilutive funding should it be required to facilitate the evolution of the business. The Loan Facility will provide the Company with additional working capital while it continues to invest in growing its services business.